Company intelligence / Profile preview

One2Treat

Louvain-la-Neuve, Belgiumone2treat.com ↗

Ownership: Private
Employees: ~11
Development stage: Other

Overview

One2Treat has developed and launched an innovative software platform that integrates patient preferences and multiple clinically relevant outcomes into a single comprehensive treatment assessment. Their approach allows biopharmaceutical sponsors to design more efficient, patient-centric clinical trials with reduced sample sizes and faster time-to-market. The recently launched "One2Treat Voice" app further enables direct incorporation of the patient voice in endpoint selection and outcome prioritization in clinical research.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Works with biopharmaceutical companies as clients/partners

Beyond the preview

Go deeper on One2Treat.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on One2Treat.

Explore the full profile